ERISA Ledger · U.S. DOL EBSA Form 5500 (2023)

Cti Biopharma CORP

Official 2023 U.S. DOL Form 5500 summary for Cti Biopharma CORP (Cti Biopharma CORP. 401(k) Plan · EIN 91-1533912 · PN 001): $18.32M net assets, 182 active participants, and $13.42 per $10,000 (13.42 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorCti Biopharma CORP
Filing IdentifierCti Biopharma CORP. 401(k) Plan · EIN 91-1533912 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2023)$18.32M
Active Participants182
Direct Admin Fee Rate$13.42 per $10,000 (13.42 bps)
Cohort Peer Median$34.74 per $10,000 (34.74 bps)
Primary Recordkeeper / ProviderHighland Capital Advisors, LLC.
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI